Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
G. Laconde, N. Pommery, P. Depreux, P. Berthelot & J.-P. Hénichart. (2003) New Analogues of the Anticancer E7070: Synthesis and Pharmacology. Journal of Enzyme Inhibition and Medicinal Chemistry 18:2, pages 89-94.
Read now
Read now
Ana Castro & Ana Martinez. (2000) Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders. Expert Opinion on Therapeutic Patents 10:10, pages 1519-1527.
Read now
Read now
John C Kath. (2000) Patent focus: inhibitors of tumour cell growth. Expert Opinion on Therapeutic Patents 10:6, pages 803-818.
Read now
Read now
Articles from other publishers (24)
Riva Yudisa Ikhsanurahman, Nurul Ikhsan & Isman Kurniawan. (2022) Classification of CDK2 Inhibitor as Anti-Cancer Agent by Using Simulated Annealing-Support Vector Machine Methods. Classification of CDK2 Inhibitor as Anti-Cancer Agent by Using Simulated Annealing-Support Vector Machine Methods.
Sunil K. Tripathi, Rajendran Naga Soundarya, Poonam Singh & Sanjeev K. Singh. (2015) Comparative Analysis of Various Electrostatic Potentials on Docking Precision Against Cyclin-Dependent Kinase 2 Protein: A Multiple Docking Approach. Chemical Biology & Drug Design 85:2, pages 107-118.
Crossref
Crossref
Marion Peyressatre, Camille Prével, Morgan Pellerano & May Morris. (2015) Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors. Cancers 7:1, pages 179-237.
Crossref
Crossref
Camille Prével, Laetitia Kurzawa, Thi Nhu Ngoc Van & May C. Morris. (2014) Fluorescent biosensors for drug discovery new tools for old targets – Screening for inhibitors of cyclin-dependent kinases. European Journal of Medicinal Chemistry 88, pages 74-88.
Crossref
Crossref
Sunil Kumar Tripathi, Ravikumar Muttineni & Sanjeev Kumar Singh. (2013) Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. Journal of Theoretical Biology 334, pages 87-100.
Crossref
Crossref
Xian-Feng Huang, Xiang Lu, Yong Zhang, Guo-Qiang Song, Qi-Long He, Qing-Shan Li, Xian-Hui Yang, Yao Wei & Hai-Liang Zhu. (2012) Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Bioorganic & Medicinal Chemistry 20:16, pages 4895-4900.
Crossref
Crossref
Roderick G. Walker, Graeme Thomson, Kirk Malone, Matthew W. Nowicki, Elaine Brown, David G. Blake, Nicholas J. Turner, Malcolm D. Walkinshaw, Karen M. Grant & Jeremy C. Mottram. (2011) High Throughput Screens Yield Small Molecule Inhibitors of Leishmania CRK3:CYC6 Cyclin-Dependent Kinase. PLoS Neglected Tropical Diseases 5:4, pages e1033.
Crossref
Crossref
Sergey Arutyunyan & Adel Nefzi. (2010) Synthesis of Chiral Polyaminothiazoles. Journal of Combinatorial Chemistry 12:3, pages 315-317.
Crossref
Crossref
K. B. Kalpana, M. Srinivasan & Venugopal P. Menon. (2008) Antioxidant potential of aminothiazole derivative and its protective effect on H2O2-induced oxidative damage on pBR322 DNA and RBC cellular membrane. Molecular and Cellular Biochemistry 314:1-2, pages 95-103.
Crossref
Crossref
Yu Mi Ahn, Lakshminarayana Vogeti, Chun-Jing Liu, Hari K.R. Santhapuram, Jonathan M. White, Veena Vasandani, Lester A. Mitscher, Gerald H. Lushington, Paul R. Hanson, Douglas R. Powell, Richard H. Himes, Katherine F. Roby, Qizhuang Ye & Gunda I. Georg. (2007) Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues. Bioorganic & Medicinal Chemistry 15:2, pages 702-713.
Crossref
Crossref
Jörg Degen & Matthias Rarey. (2006) FlexNovo: Structure-Based Searching in Large Fragment Spaces. ChemMedChem 1:8, pages 854-868.
Crossref
Crossref
Kumaran G. Sreejalekshmi, Satyabhama K.C. Devi & Kallikat N. Rajasekharan. (2006) An efficient protocol for solid phase aminothiazole synthesis. Tetrahedron Letters 47:35, pages 6179-6182.
Crossref
Crossref
. (2005) Synthesis of Naringenin Amino Acid Esters as Potential CDK2 Inhibitors. Bulletin of the Korean Chemical Society 26:12, pages 2065-2068.
Crossref
Crossref
Scott N. VanderWel, Patricia J. Harvey, Dennis J. McNamara, Joseph T. Repine, Paul R. Keller, John Quin, R. John Booth, William L. Elliott, Ellen M. Dobrusin, David W. Fry & Peter L. Toogood. (2005)
Pyrido[2,3-
d
]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4
. Journal of Medicinal Chemistry 48:7, pages 2371-2387.
Crossref
Crossref
Peter L. Toogood, Patricia J. Harvey, Joseph T. Repine, Derek J. Sheehan, Scott N. VanderWel, Hairong Zhou, Paul R. Keller, Dennis J. McNamara, Debra Sherry, Tong Zhu, Joanne Brodfuehrer, Chung Choi, Mark R. Barvian & David W. Fry. (2005) Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6. Journal of Medicinal Chemistry 48:7, pages 2388-2406.
Crossref
Crossref
Rui Zhou, Ze-Hua Yu, Xiao-qing Li, Fang Jia, Jian-hong Wu & Xinwen Chen. (2004) Heliocoverpa armigera single nucleocapsid nucleopolyhedrovirus induces Hz-AM1 cell cycle arrest at the G2 phase with accumulation of cyclin B1. Virus Research 105:2, pages 113-120.
Crossref
Crossref
Apos Dermatakis, Kin-Chun Luk & Wanda DePinto. (2003) Synthesis of Potent Oxindole CDK2 Inhibitors. Bioorganic & Medicinal Chemistry 11:8, pages 1873-1881.
Crossref
Crossref
Marie Knockaert & Laurent Meijer. (2002) Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography. Biochemical Pharmacology 64:5-6, pages 819-825.
Crossref
Crossref
Marie Knockaert, Karen Wieking, Sophie Schmitt, Maryse Leost, Karen M. Grant, Jeremy C. Mottram, Conrad Kunick & Laurent Meijer. (2002) Intracellular Targets of Paullones. Journal of Biological Chemistry 277:28, pages 25493-25501.
Crossref
Crossref
Joseph Schoepfer, Heinz Fretz, Bhabatosh Chaudhuri, Lionel Muller, Egge Seeber, Laurent Meijer, Olivier Lozach, Eric Vangrevelinghe & Pascal Furet. (2002) Structure-Based Design and Synthesis of 2-Benzylidene-benzofuran-3-ones as Flavopiridol Mimics. Journal of Medicinal Chemistry 45:9, pages 1741-1747.
Crossref
Crossref
Peter L. Toogood. (2001) Cyclin-dependent kinase inhibitors for treating cancer. Medicinal Research Reviews 21:6, pages 487-498.
Crossref
Crossref
Alexander J. Bridges. (2001) Chemical Inhibitors of Protein Kinases. Chemical Reviews 101:8, pages 2541-2572.
Crossref
Crossref
Mark Barvian, Diane H. Boschelli, Jennifer Cossrow, Ellen Dobrusin, Ali Fattaey, Alex Fritsch, David Fry, Patricia Harvey, Paul Keller, Michelle Garrett, Frances La, Wilbur Leopold, Dennis McNamara, Maire Quin, Susanne Trumpp-Kallmeyer, Peter Toogood, Zhipei Wu & Erli Zhang. (2000)
Pyrido[2,3-
d
]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases
. Journal of Medicinal Chemistry 43:24, pages 4606-4616.
Crossref
Crossref
Kyoung Soon Kim, John S. Sack, John S. Tokarski, Ligang Qian, Sam T. Chao, Leslie Leith, Yolanda F. Kelly, Raj N. Misra, John T. Hunt, S. David Kimball, William G. Humphreys, Barris S. Wautlet, Janet G. Mulheron & Kevin R. Webster. (2000) Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors: Synthesis and Biological Effects. Journal of Medicinal Chemistry 43:22, pages 4126-4134.
Crossref
Crossref